Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

NSE:ADVENZYMES Statistics

Total Valuation

NSE:ADVENZYMES has a market cap or net worth of INR 38.06 billion. The enterprise value is 33.01 billion.

Market Cap	38.06B
Enterprise Value	33.01B

Important Dates

The next estimated earnings date is Friday, November 7, 2025.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	Jul 23, 2025

Share Statistics

NSE:ADVENZYMES has 111.88 million shares outstanding. The number of shares has increased by 0.00% in one year.

Current Share Class	111.88M
Shares Outstanding	111.88M
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	46.44%
Owned by Institutions (%)	12.90%
Float	29.32M

Valuation Ratios

The trailing PE ratio is 27.82 and the forward PE ratio is 24.30. NSE:ADVENZYMES's PEG ratio is 1.43.

PE Ratio	27.82
Forward PE	24.30
PS Ratio	5.70
PB Ratio	2.59
P/TBV Ratio	3.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.43

Enterprise Valuation

EV / Earnings	24.11
EV / Sales	4.94
EV / EBITDA	16.89
EV / EBIT	20.34
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.03
Debt / EBITDA	0.20
Debt / FCF	n/a
Interest Coverage	47.08

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	6.93%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	19.77M
Profits Per Employee	4.05M
Employee Count	338
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:ADVENZYMES has paid 541.53 million in taxes.

Income Tax	541.53M
Effective Tax Rate	27.97%

Stock Price Statistics

The stock price has decreased by -25.88% in the last 52 weeks. The beta is 0.37, so NSE:ADVENZYMES's price volatility has been lower than the market average.

Beta (5Y)	0.37
52-Week Price Change	-25.88%
50-Day Moving Average	326.55
200-Day Moving Average	320.86
Relative Strength Index (RSI)	58.47
Average Volume (20 Days)	1,293,223

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:ADVENZYMES had revenue of INR 6.68 billion and earned 1.37 billion in profits. Earnings per share was 12.23.

Revenue	6.68B
Gross Profit	4.87B
Operating Income	1.62B
Pretax Income	1.94B
Net Income	1.37B
EBITDA	1.88B
EBIT	1.62B
Earnings Per Share (EPS)	12.23

Balance Sheet

The company has 5.92 billion in cash and 393.50 million in debt, giving a net cash position of 5.53 billion or 49.42 per share.

Cash & Cash Equivalents	5.92B
Total Debt	393.50M
Net Cash	5.53B
Net Cash Per Share	49.42
Equity (Book Value)	14.69B
Book Value Per Share	127.00
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 72.90%, with operating and profit margins of 24.28% and 20.48%.

Gross Margin	72.90%
Operating Margin	24.28%
Pretax Margin	28.97%
Profit Margin	20.48%
EBITDA Margin	28.19%
EBIT Margin	24.28%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 5.20, which amounts to a dividend yield of 1.53%.

Dividend Per Share	5.20
Dividend Yield	1.53%
Dividend Growth (YoY)	1.96%
Years of Dividend Growth	4
Payout Ratio	n/a
Buyback Yield	-0.00%
Shareholder Yield	1.53%
Earnings Yield	3.60%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 25, 2017. It was a forward split with a ratio of 5.

Last Split Date	May 25, 2017
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	1